Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012735 · ClinicalTrials.gov registry record · Phase 1
A Study of a Hydrocolloid Bandage on Pimples
A Phase 1 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT05012735: Completed Phase 1 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
NCT05012735 is a Phase 1 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 41 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05012735, a Phase 1 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.
Primary Outcome
Change from baseline in general wound appearance of the popped pimple will be assessed. It is evaluated on a scale from 0 to 4 with 0=poor (new or fresh wound with the epithelium layer missing, wound bed appears raw and possibly oozing); 1=fair (epithelial growth is starting to occur, wound bed is dry); 2=good (epithelial growth is clearly evident, wound bed color is no more than moderate erythema, scabbing may be present); 3=very good (wound bed indentation is slightly visible, wound area is mo
Interventions
- DRUG Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5)
- DEVICE Prototype Ultrathin Hydrocolloid Bandage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2021-09-13 |
| Phase | Phase 1 |
What the finished NCT05012735 record still lists
NCT05012735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 2 interventions - of which Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) is the first listed.
NCT05012735 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05012735 about?
NCT05012735 is a clinical study titled "A Study of a Hydrocolloid Bandage on Pimples". The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.
What is the current status of trial NCT05012735?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2021-07-19. Estimated completion is 2021-09-13.
What interventions are being tested in trial NCT05012735?
The interventions under investigation include: Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) (DRUG), Prototype Ultrathin Hydrocolloid Bandage (DEVICE).
Who is sponsoring clinical trial NCT05012735?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05012735's enrollment target sits among peer trials
41 1125th of 2000 higher than 871 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI